Transcriptomic characterization of culture-associated changes in murine and human precision-cut tissue slices

• Published in: Archives of toxicology 2019-12, Vol.93 (12), p.3549-3583
• Main Authors: Bigaeva, Emilia, Gore, Emilia, Simon, Eric, Zwick, Matthias, Oldenburger, Anouk, de Jong, Koert P., Hofker, Hendrik S., Schlepütz, Marco, Nicklin, Paul, Boersema, Miriam, Rippmann, Jörg F., Olinga, Peter
• Format: Article
• Language: English
• Subjects: Animal diseases; Animal models; Biological activity; Biomedical and Life Sciences; Biomedical materials; Biomedicine; Disease control; Drug development; Environmental Health; Extracellular matrix; Fibrosis; Gene expression; Gene regulation; Gene sequencing; HMGB1 protein; Ileum; In Vitro Systems; Inflammation; Inflammatory response; Interleukin 11; Interleukin 6; Interleukin 8; Kidneys; Liver; Liver diseases; Occupational Medicine/Industrial Medicine; Organs; Osteoarthritis; Pathology; Pharmacology/Toxicology; Signal transduction; Signaling; Stromelysin 2; Tissues; Transcription
• ISSN: 0340-5761; 1432-0738
• DOI: 10.1007/s00204-019-02611-6

Our knowledge of complex pathological mechanisms underlying organ fibrosis is predominantly derived from animal studies. However, relevance of animal models for human disease is limited; therefore, an ex vivo model of human precision-cut tissue slices (PCTS) might become an indispensable tool in fibrosis research and drug development by bridging the animal–human translational gap. This study, presented as two parts, provides comprehensive characterization of the dynamic transcriptional changes in PCTS during culture by RNA sequencing. Part I investigates the differences in culture-induced responses in murine and human PCTS derived from healthy liver, kidney and gut. Part II delineates the molecular processes in cultured human PCTS generated from diseased liver, kidney and ileum. We demonstrated that culture was associated with extensive transcriptional changes and impacted PCTS in a universal way across the organs and two species by triggering an inflammatory response and fibrosis-related extracellular matrix (ECM) remodelling. All PCTS shared mRNA upregulation of IL-11 and ECM-degrading enzymes MMP3 and MMP10. Slice preparation and culturing activated numerous pathways across all PCTS, especially those involved in inflammation (IL-6, IL-8 and HMGB1 signalling) and tissue remodelling (osteoarthritis pathway and integrin signalling). Despite the converging effects of culture, PCTS display species-, organ- and pathology-specific differences in the regulation of genes and canonical pathways. The underlying pathology in human diseased PCTS endures and influences biological processes like cytokine release. Our study reinforces the use of PCTS as an ex vivo fibrosis model and supports future studies towards its validation as a preclinical tool for drug development.